Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069602 · ClinicalTrials.gov registry record · Phase 4
Assessing Continuous Glucose Monitors in Healthy Children
A Phase 4 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00069602: Completed Phase 4 study, sponsored by Jaeb Center for Health Research.
NCT00069602 is a Phase 4 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 20 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00069602, a Phase 4 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Continuous glucose monitors may be useful in the treatment of children with Type 1 diabetes mellitus. The purpose of this study was to determine whether two FDA-approved continuous glucose monitors, the Continuous Glucose Monitoring System (CGMS) and the GlucoWatch G2TM Biographer (GW2B), are sufficiently accurate to use in future studies to characterize glucose levels in children.
Interventions
- DEVICE Continuous Glucose Monitoring System (CGMS)
- DEVICE GlucoWatch G2TM Biographer (GW2B)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2002-08 |
| Est. Completion | 2002-11 |
| Phase | Phase 4 |
What the finished NCT00069602 record still lists
NCT00069602 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitoring System (CGMS) is the first listed.
NCT00069602 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00069602 about?
NCT00069602 is a clinical study titled "Assessing Continuous Glucose Monitors in Healthy Children". Continuous glucose monitors may be useful in the treatment of children with Type 1 diabetes mellitus. The purpose of this study was to determine whether two FDA-approved continuous glucose monitors, the Continuous Glucose Monitoring System (CGMS) and the GlucoWatch G2TM Biographer (GW2B), are suffic...
What is the current status of trial NCT00069602?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2002-08. Estimated completion is 2002-11.
What interventions are being tested in trial NCT00069602?
The interventions under investigation include: Continuous Glucose Monitoring System (CGMS) (DEVICE), GlucoWatch G2TM Biographer (GW2B) (DEVICE).
Who is sponsoring clinical trial NCT00069602?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00069602's enrollment target sits among peer trials
20 1753rd of 2000 higher than 167 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia